Developing novel small RNA blood tests to improve human health
What drives us
Explore Hummingbird’s DiagnosticS pipeline for multiple diseases
Broad pipeline of proprietary, small RNA-based tests from blood.
PREDICTION OF RESPONSE TO IMMUNOTHERAPY
•Blood-based small RNA panel that predicts immunotherapy response in stage IV NSCLC
•Significant and improved survival prediction (better than PD-L1 staining)
•Significant and immediate value for patients
EARLY DETECTION OF LUNG CANCER
•Blood-based small RNA panel that detects early-stage NSCLC
•Best performance reported from a blood test for early-stage lung cancer
Tackling unmet medical needs
Explore HumminGbird’s Pharma service options
Open to all kinds of partnering and collaboration projects involving small RNAs and Hummingbird’s highly sensitive, robust, and AI powered Next-Gen technology platform independent of the disease and application.